Table 4 Sensitivity analysis 2 - Influence of PDC rates on health care expenditures

(Intercept)

10,032.21

840.93

11.93

0.0000***

Age

55 < 65

−105.27

573.67

−0.18

0.8544

65 < 75

−44.58

537.60

−0.08

0.9339

≥ 75

− 1067.64

546.18

−1.95

0.0507

Gender

female

−58.70

274.20

−0.21

0.8305

BMI

underweight

1949.13

1756.07

1.11

0.2671

overweight

− 228.12

331.73

−0.69

0.4917

obese

− 140.00

352.75

−0.40

0.6915

BIMD 2010 (Q1 least deprived, Q5 most deprived)

Q2

−505.20

371.50

−1.36

0.1739

Q3

− 738.01

404.06

−1.83

0.0678

Q4

− 545.68

398.88

−1.37

0.1713

Q5

−768.79

376.58

−2.04

0.0412*

Smoker

yes

183.30

387.00

0.47

0.6358

NYHA

1

1852.93

707.26

2.62

0.0088**

2

1539.45

414.21

3.72

0.0002***

3

2743.89

381.06

7.20

0.0000***

4

4034.88

422.76

9.54

0.0000***

DMP COPD

yes

310.39

477.84

0.65

0.5160

DMP asthma

yes

− 681.41

731.89

−0.93

0.3519

DMP diabetes type 1

yes

2067.03

1966.07

1.05

0.2931

DMP diabetes type 2

yes

424.88

253.61

1.68

0.0939

HMG assignments per month

1.41

0.24

5.77

0.0000***

Year after AMI

− 5133.93

155.94

−32.92

0.0000***

Angina pectoris

1766.07

249.36

7.08

0.0000***

Peripheral vascular disease

3727.85

358.26

10.41

0.0000***

Dyslipidemia

737.41

334.28

2.21

0.0274*

Congestive heart failure

1761.57

308.12

5.72

0.0000***

Hypertension

1925.66

520.03

3.70

0.0002***

Dialysis

25,186.07

1035.41

24.32

0.0000****

edf

Ref.df

F

p-value

s (PDC mean ACE inhibitors) male

1.00

1.00

0.26

0.6135

s (PDC mean ACE inhibitors) female

1.00

1.00

2.44

0.1179

s (PDC mean β-blockers) male

1.00

1.00

0.01

0.9286

s (PDC mean β-blockers) female

1.00

1.00

0.01

0.9118

s (PDC mean statins) male

1.00

1.00

3.84

0.0500

s (PDC mean statins) female

1.00

1.00

0.03

0.8529

s (PDC mean anti-platelet agents) male

2.43

2.43

10.20

0.0000***

s (PDC mean anti-platelet agents) female

1.00

1.00

9.76

0.0018**

s (PDC standard deviation ACE inhibitors) male

2.93

2.93

4.86

0.0023**

s (PDC standard deviation ACE inhibitors) female

2.87

2.87

6.88

0.0002***

s (PDC standard deviation β-blockers) male

4.70

4.70

17.23

0.0000***

s (PDC standard deviation β-blockers) female

1.00

1.00

3.78

0.0520

s (PDC standard deviation statins) male

1.18

1.18

1.06

0.3681

s (PDC standard deviation statins) female

3.59

3.59

3.45

0.0136*

s (PDC standard deviation anti-platelet agents) male

3.42

3.42

8.22

0.0000***

s (PDC standard deviation anti-platelet agents) female

2.93

2.93

9.49

0.0000***